Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kelly

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Cancers|June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow UpSean Ong, Claire Pascoe, Brian D Kelly, et al.
Molecular Pharmaceutics|December 22, 2010
Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Blood|September 18, 2004
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1Dominador J Manalo, Ashley Rowan, Tera Lavoie, et al.
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2011
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsLisa M Kaminskas, Victoria M McLeod, Brian D Kelly, et al.
Journal of Pharmaceutical Sciences|June 1, 2018
Doxorubicin Conjugation and Drug Linker Chemistry Alter the Intravenous and Pulmonary Pharmacokinetics of a PEGylated Generation 4 Polylysine Dendrimer in RatsNathania J Leong, Dharmini Mehta, Victoria M McLeod, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 20, 2017
Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection siteGemma M Ryan, Victoria M McLeod, Dharmini Mehta, et al.
Methods (San Diego, Calif.)|July 13, 2010
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as modelsHiroaki Nitta, Wenjun Zhang, Brian D Kelly, et al.
Ecology and Evolution|April 10, 2019
Chronology of reproductive investment determines predation risk aversion in a felid-ungulate systemDaniel A Crawford, Michael J Cherry, Brian D Kelly, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Cancers|June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow UpSean Ong, Claire Pascoe, Brian D Kelly, et al.
Molecular Pharmaceutics|December 22, 2010
Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Blood|September 18, 2004
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1Dominador J Manalo, Ashley Rowan, Tera Lavoie, et al.
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2011
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsLisa M Kaminskas, Victoria M McLeod, Brian D Kelly, et al.
Journal of Pharmaceutical Sciences|June 1, 2018
Doxorubicin Conjugation and Drug Linker Chemistry Alter the Intravenous and Pulmonary Pharmacokinetics of a PEGylated Generation 4 Polylysine Dendrimer in RatsNathania J Leong, Dharmini Mehta, Victoria M McLeod, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 20, 2017
Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection siteGemma M Ryan, Victoria M McLeod, Dharmini Mehta, et al.
Methods (San Diego, Calif.)|July 13, 2010
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as modelsHiroaki Nitta, Wenjun Zhang, Brian D Kelly, et al.
Ecology and Evolution|April 10, 2019
Chronology of reproductive investment determines predation risk aversion in a felid-ungulate systemDaniel A Crawford, Michael J Cherry, Brian D Kelly, et al.
Pageof 7